Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
- DOI
- 10.1186/s12885-025-13633-y
- Published
- 2025-02-07
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-025-13633-y,
title = {Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia},
author = {Fei Xie and Ting-juan Zhang and Xin-long Zhang and Zi-jun Xu and Liang Qiao and Yun Wang and Yang-jing Zhao and Jun Qian and Jing-dong Zhou},
year = {2025},
journal = {BMC Cancer},
doi = {10.1186/s12885-025-13633-y},
url = {https://doi.org/10.1186/s12885-025-13633-y}
}RIS
TY - JOUR TI - Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia AU - Fei Xie AU - Ting-juan Zhang AU - Xin-long Zhang AU - Zi-jun Xu AU - Liang Qiao AU - Yun Wang AU - Yang-jing Zhao AU - Jun Qian AU - Jing-dong Zhou PY - 2025 JO - BMC Cancer DO - 10.1186/s12885-025-13633-y UR - https://doi.org/10.1186/s12885-025-13633-y ER -
APA
Xie, F., Zhang, T., Zhang, X., Xu, Z., Qiao, L., Wang, Y., Zhao, Y., Qian, J., & Zhou, J. (2025). Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia. BMC Cancer. https://doi.org/10.1186/s12885-025-13633-y
Source records
- crossref · retrieved 2026-09-26T18:58:17.345Z